Ipsen ($GB:0MH6) announced an update on their ongoing clinical study. Study Overview: Ipsen recently completed a study titled A Multicentre, ...
NORTH CHICAGO, Ill., Oct. 6, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 2 ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA ...
FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity
Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...
Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...
While the Food and Drug Administration (FDA) hasn’t approved Botox for trigeminal neuralgia, doctors may prescribe the drug off-label for this use. Several studies have looked into the effectiveness ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback